Suman Kambhampati, M.D.

Rank: Associate Professor of Medicine
Position: Director, Myelodysplastic Syndrome and Elderly Leukemia

Clinical Interests

Begin and Malignant Hematologic Disorders | Leukemia | Multiple Myeloma | 
Chronic Lymphoctyic Leukemia

Research Interests

Signal transduction pathways involving nuclear receptors
Role of Protein kinase C and MAP kinase pathways in malignant cells
Study the role of Wnt signaling pathway in Barrett's Esophageal Adenocarcinoma development
Study the role played by ß-catenin and its signaling partners in the evolution of Barrett's Esophagus-induced Esophageal Adenocarcinoma

Publications

---

Education and Training

Medical school: Karnatak University, India (MBBS)
Medical school: University of Illinois, Chicago (MD)
Internship: University of Illinois, Chicago (Neuropsychiatry)
Residency: Safdarjung Hospital, New Delhi, India
Residency: Wellington Hospital, New Delhi, India
Residency: University of Illinois, Chicago (Internal Medicine)
Fellowship: University of Illinois, Chicago (Hematology Oncology and Research)
Fellowship: Feinberg School of Medicine, Northwestern University, Chicago (Hematology Oncology and Research)

Awards

• Honors in Biochemistry, Anatomy, Physiology, Pharmacology, and Medicine, State University Examination
• Alpha Omega Alpha Medical Honor Society
• Voted as the best third year resident by the Internal Medicine Faculty, University of Illinois
• Lauri Stauss Leukemia Foundation Research Fellow
• The Global Directory of Who's Who, Selected
• Department of Veteran Affairs Special Contribution Award for Research
• Department of Veteran Affairs Special Contribution Award for Clinical Practice
• Excellence in Research Award, Kansas City Veteran Affairs
• Kansas NIH COBRE First Award in Cancer Experimental Therapeutics Grant Competition
• Department of Veteran Affairs Special Contribution Award for Clinical Practice
• Association of Veteran Affairs Hematology and Oncology

Organizations

• American Board of Internal Medicine
• American Society of Clinical Oncology
• American Society of Hematology
• Southwest Oncology Group
• American Association for Cancer Research
• Association of Veteran Affairs Hematology and Oncology
• Topeka Veteran Affairs Medical Center Transfusion and Pathology Review Committee
• Kansas City Veteran Affairs Medical Center Transfusion Committee
• Kansas City Veteran Affairs Medical Center Pharmacy and Therapeutics Committee
• Kansas University Cancer Center
• Kansas City Veteran Affairs Medical Center Cancer Program Committee
• Physician-in-charge of VISN 15 Erythropoietin Stimulating Agents
• Veteran Affairs National Pharmacy Benefits Management (PBM) Medical Advisory Panel (MAP), Consultant
• American College of Surgeons, Commission on Cancer, Cancer Liaison Physician
• Association of Veteran Affairs Hematology and Oncology, Board Member
• Veteran Health Administration, National Committee for Bone Marrow Transplant/Stem Cell Transplant Program
• Institutional Review Board, Kansas City Clinical Community Oncology Program (KC CCOP)